The laser targets blood-vessel connections on the shared placenta and coagulates them, which stops or reduces the abnormal exchange of blood between the fetuses. This intervention addresses the vascular source of the imbalance rather than only its effects. Separating the circulations can help limit the harmful transfusion pattern associated with twin-to-twin transfusion syndrome.
A shared placenta can contain vascular connections linking the circulations of the fetuses. When blood flow through those connections becomes harmful, one fetus may receive too much while the other receives too little. Fetal laser therapy focuses on these placental connections, making the placenta the treatment site and allowing clinicians to address the underlying circulation problem.
In twin-to-twin transfusion syndrome, unequal blood transfer creates opposing risks: one twin receives an excessive supply, while the other experiences insufficient blood flow. By coagulating the connecting vessels, treatment aims to reduce this harmful exchange before birth. The goal is to improve the conditions supporting one or both fetuses during the remainder of pregnancy.
Clinicians perform fetoscopy to examine and treat the vascular connections on the shared placenta. Using the fetoscopic approach, they direct a laser to coagulate the vessels responsible for the abnormal transfusion pattern. This provides a minimally invasive way to intervene during pregnancy and directly target the placental circulation involved in the complication.
The procedure is most commonly associated with twin-to-twin transfusion syndrome, a serious complication involving abnormal blood exchange between fetuses sharing a placenta. Clinicians use it before birth when the placental circulation is creating a harmful imbalance. Its purpose is to treat the underlying vascular problem while the fetuses remain in the uterus.
Fetal laser therapy represents an important maternal-fetal medicine approach because it allows clinicians to treat a serious fetal complication before birth rather than waiting until delivery. Its minimally invasive design combines fetoscopy with targeted treatment of placental vessels. By addressing abnormal circulation during pregnancy, the technique can improve outcomes for one or more fetuses.